This website uses first-party and third-party cookies to enhance our services and show you information related to your preferences by analysing your browsing habits. By continuing to browse our website you accept our use of cookies. You can change the settings or get more information by visiting our Cookies Policy.

European approval as a class III medical device:

UTIPRO PLUS® is intended for the control and prevention of urinary tract infections produced by pathogens such as E.coli and other gram (-) bacteria normally involved in the etiology of urological infections.

The compound, based on Gelatin and Xyloglucan (Hemicellulose), acts mechanically in the intestinal lumen, avoiding the contact of the pathogens with the intestinal mucosa, which is the first step for their proliferation and subsequent passage to the urinary tract.

UTIPRO PLUS® is to be taken orally, from the appearance of the first symptoms of urinary tract disorders, with the aim of reducing the proliferation of pathogens that may degenerate into infections. In case of infection recurrences, UTIPRO PLUS® is also intended for the prevention of new episodes, in which the proliferation of pathogen cause repeated urinary tract infection.

UTIPRO PLUS® is available in capsules for oral use and is already marketed in several European countries. Further registrations are pending within and outside the EU.

All currently available products are supported by strong scientific evidences published on reputable journals.

       
This area contains information intended exclusively for health professionals authorized to prescribe or dispense pharmaceutical products.
   
Calle Consejo de Ciento, 333
08007 Barcelona, Spain

Contact us

info@noventure.com
NOVENTURE S.L.
Tel: +34.93.205.27.18